Tag: licensing
-
Key Molecular Factors Uncovered Behind Tick-Borne Bacteria
Medical researchers at Virginia Commonwealth University in Richmond, with colleagues from Yale University and University of California in Davis, identified pathways and processes used by bacteria responsible for some tick-transmitted diseases to infect humans and animals. The team led by VCU’s Jason Carlyon published its findings in the November issue of the journal Infection and…
-
University Spin-Off Developing Super-Porous Nanomaterials
A spin-off company from Queen’s University in Belfast, Northern Ireland is commercializing research on highly porous nanoscale materials, using a simple, safe process for synthesizing these materials developed at the university. The research by Queens chemistry professor Stuart James on these materials, known as metal-organic frameworks (MOFs), has led to the founding of the company…
-
University Licenses Taste-Masking Technology to Pharma
New Jersey Institute of Technology in Newark agreed to license its discoveries that can mask the taste of drug particles to Catalent Pharma Solutions, a drug manufacturer in Somerset, New Jersey. Catalent funded the research by NJIT engineering professor Rajesh Dave (pictured left) that led to the development of this technology. Dave’s research at NJIT…
-
AstraZeneca Licenses Kidney Disease Complications Treatment
AstraZeneca, a global pharmaceutical company based in the U.K., agreed to license a compound to treat complications of chronic and end-stage kidney disease from Ardelyx in Fremont, California. The deal that provides AstraZeneca with an exclusive worldwide license has a value of at least $272.5 million. Ardelyx develops small molecule drugs that restrict absorption in…
-
CT Image Analytics Adapted for COPD Diagnosis
Medical researchers at University of Michigan in Ann Arbor adapted computed tomography (CT) image analysis techniques to more precisely diagnose chronic obstructive pulmonary disease, or COPD. The research team led by Michigan radiologist Brian Ross appears online in the journal Nature Medicine (paid subscription required). Ross and colleagues also founded a company that is taking…
-
GE Expands Geron Corp. Stem Cell Licensing Deal
GE Healthcare, a division of General Electric Company, is expanding its licensing agreement with biopharmaceutical company Geron Corp. in Menlo Park, California for stem cell tests used in drug discovery. Financial terms of the deal were not disclosed. In 2009, Geron agreed to license its human embryonic stem cells technology to GE Healthcare for the…
-
Bristol-Myers, Vanderbilt to Partner on Parkinson’s Drugs
Pharmaceutical company Bristol-Myers Squibb and Vanderbilt University in Nashville will collaborate on new treatments for Parkinson’s disease, a progressive brain disorder. The financial magnitude and length of the multi-year agreement were not disclosed. Under the deal, Vanderbilt’s Center for Neuroscience Drug Discovery will identify drug candidates from current research being supported by the Michael J.…
-
FDA Approves Inhaled Aerosol Asthma Maintenance Drug
Acton Pharmaceuticals Inc. in Marlborough, Massachusetts reports the U.S. Food and Drug Administration approved its drug Aerospan, an orally inhaled corticosteroid for the prevention of asthma attacks. The FDA approval, says Acton, came in response to a supplemental new drug application, and will enable the company to launch the drug in the U.S. during the…
-
Home Computer Fetal Ultrasound System Developed
Engineers at Newcastle University in the U.K. created a low-cost ultrasound scanner that can display images of a fetus on a home computer display. The device aims to make the monitoring of fetal development a more routine task, particularly in less developed areas of the world. The scanner, about the size of a computer mouse,…
-
Levitation Technique Devised to Create More Soluble Drugs
Researchers at Argonne National Laboratory, a division of the U.S. Department of Energy in Illinois, developed techniques making it more feasible to create drugs that are more soluble, and thus more effective in lower doses. X-ray physicist Chris Benmore led the study that uses levitation to suspend the solution in air while it evaporates, leaving…